These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31439274)

  • 1. Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' reply.
    Dennis JM; Shields BM; Henley WE; Jones AG; Hattersley AT
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):669. PubMed ID: 31439274
    [No Abstract]   [Full Text] [Related]  

  • 2. Clusters provide a better holistic view of type 2 diabetes than simple clinical features.
    Ahlqvist E; Tuomi T; Groop L
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):668-669. PubMed ID: 31439272
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes clusters and risk of diabetes-associated diseases - Authors' reply.
    Zaharia OP; Kuss O; Strassburger K; Burkart V; Szendroedi J; Roden M
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):828-829. PubMed ID: 31621588
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 diabetes - Authors' reply.
    Chatterjee S; Khunti K; Davies MJ
    Lancet; 2018 Mar; 391(10127):1262. PubMed ID: 29619960
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive periodontal therapy and type 2 diabetes - Authors' reply.
    D'Aiuto F; Deanfield JE
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):175-176. PubMed ID: 30782467
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 1 diabetes-origins and epidemiology - Authors' reply.
    Norris JM; Johnson RK; Stene LC
    Lancet Diabetes Endocrinol; 2020 May; 8(5):369-370. PubMed ID: 32333871
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic risk scores in adult-onset type 1 diabetes - Authors' reply.
    Thomas NJ; Jones SE; Weedon MN; Shields BM; Hattersley AT; Oram RA
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):169. PubMed ID: 29475496
    [No Abstract]   [Full Text] [Related]  

  • 8. β-cell secretory dysfunction: a key cause of type 2 diabetes - Authors' reply.
    Weir GC; Gaglia J; Bonner-Weir S
    Lancet Diabetes Endocrinol; 2020 May; 8(5):370-371. PubMed ID: 32333872
    [No Abstract]   [Full Text] [Related]  

  • 9. Achieving replicable subphenotypes of adult-onset diabetes - Authors' reply.
    Stefan N; Schulze MB
    Lancet Diabetes Endocrinol; 2023 Sep; 11(9):636-637. PubMed ID: 37536357
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data.
    Dennis JM; Shields BM; Henley WE; Jones AG; Hattersley AT
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):442-451. PubMed ID: 31047901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer is becoming the leading cause of death in diabetes - Authors' reply.
    Davies MJ; Ahmad E; Lim S; Lamptey R; Webb DR
    Lancet; 2023 Jun; 401(10391):1849-1850. PubMed ID: 37270234
    [No Abstract]   [Full Text] [Related]  

  • 12. Exercise and physical activity in patients with type 1 diabetes - Authors' reply.
    Riddell MC; Gallen IW; Rabasa-Lhoret R;
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):493-494. PubMed ID: 28533138
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe Lead Toxicity Due to Ayurvedic Medicine in a Child with Type 1 Diabetes Mellitus: Authors' Reply.
    Jain V; Roy K
    Indian J Pediatr; 2022 Jun; 89(6):634. PubMed ID: 35298771
    [No Abstract]   [Full Text] [Related]  

  • 14. The Authors' Reply: Type 2 Diabetes and Simultaneous Pancreas-kidney Transplantation.
    Chadban SJ; Knoll GA
    Transplantation; 2021 Aug; 105(8):e93. PubMed ID: 34291771
    [No Abstract]   [Full Text] [Related]  

  • 15. Excess mortality and cardiovascular disease risk in type 1 diabetes - Authors' reply.
    Rawshani A; Sattar N; Franzén S; Rawshani A; Gudbjörnsdottir S
    Lancet; 2019 Mar; 393(10175):985-986. PubMed ID: 30860049
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular disease risk in type 1 diabetes - Authors' reply.
    Huxley RR; Peters SA; Mishra GD; Woodward M
    Lancet Diabetes Endocrinol; 2015 May; 3(5):317. PubMed ID: 25943754
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial fibrillation and type 1 diabetes - Authors' reply.
    Lind M; Rosengren A
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):937. PubMed ID: 29173502
    [No Abstract]   [Full Text] [Related]  

  • 18. Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus. Authors' reply.
    Grzelka-Woźniak A; Uruska A; Szymańska-Garbacz E; Araszkiewicz A; Jabłkowski M; Czupryniak L; Zozulińska-Ziółkiewicz D
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 37646594
    [No Abstract]   [Full Text] [Related]  

  • 19. "Physical exercise and dementia in patients with type 2 diabetes mellitus". Authors' reply.
    Bertram S; Brixius K; Brinkmann C
    Endocrine; 2016 Dec; 54(3):840. PubMed ID: 27696250
    [No Abstract]   [Full Text] [Related]  

  • 20. Disentangling the association between diabetes and bone disease - Authors' reply.
    Shanbhogue VV; Hansen S; Frost M; Brixen K; Hermann AP
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):769-770. PubMed ID: 28938995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.